Rebate Climate, Amazon Doom Cigna's Rx Deal, Icahn Says
Activist investor Carl Icahn on Thursday lobbed his latest attack against Cigna's proposed $67 billion bid for Express Scripts, warning that burgeoning competitor Amazon and growing calls to end revenue-driving rebates...To view the full article, register now.
Already a subscriber? Click here to view full article